Northern California Research Corp   Report issue

For profit Phase 2 Phase 3
Founded: Sacramento CA United States (1999)

Organization Overview

First Clinical Trial
2006
NCT00285207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Northern CA Research

Active Ingredients

Drugs in Phase 3 Trials (2)

estradiol (progynon depot) (1 trial)

estrogen (1 trial)

Drugs in Phase 2 Trials (1)

sivifene (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 2)

Neoplasms (Phase 2)

Squamous Intraepithelial Lesions of the Cervix (Phase 2)

Uterine Cervical Dysplasia (Phase 2)

Vaginitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3